Skip to main content
logo
Nanjing Vazyme Biotech Co., Ltd (SHA:688105)
China flag China · Delayed Price · Currency is CNY
23.52
-0.09 (-0.38%)
Jul 16, 2025, 3:00 PM CST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
Biological Reagent
943.66M
Log In
Log In
Log In
Log In
Upgrade
Biological Reagent Growth
-34.33%
Log In
Log In
Log In
Log In
Upgrade
Diagnostic Reagent
248.30M
Log In
Log In
Log In
Log In
Upgrade
Diagnostic Reagent Growth
-87.65%
Log In
Log In
Log In
Log In
Upgrade
Technical Services
59.59M
Log In
Log In
Log In
Log In
Upgrade
Technical Services Growth
-41.73%
Log In
Log In
Log In
Log In
Upgrade
Diagnostic Instrument
20.77M
Log In
Log In
Log In
Log In
Upgrade
Diagnostic Instrument Growth
32.00%
Log In
Log In
Log In
Log In
Upgrade
Materials and Other Materials
11.26M
Log In
Log In
Log In
Log In
Upgrade
Other Business
2.41M
Log In
Log In
Log In
Log In
Upgrade
Other Business Growth
-36.87%
Log In
Log In
Log In
Log In
Upgrade
Biological Reagent - Quantitative Polymerase Chain Reaction Series
-
Log In
Log In
Log In
Log In
Upgrade
Biological Reagent - Quantitative Polymerase Chain Reaction Series Growth
-
Log In
Log In
Log In
Log In
Upgrade
Point-of-care Testing Diagnostic Reagent - Colloidal Gold Immunochromatographic Reagent
-
Log In
Log In
Log In
Log In
Upgrade
Biological Reagent - Polymerase Chain Reaction Series
-
Log In
Log In
Log In
Log In
Upgrade
Biological Reagent - Polymerase Chain Reaction Series Growth
-
Log In
Log In
Log In
Log In
Upgrade
Biological Reagent - Gene Sequencing Series
-
Log In
Log In
Log In
Log In
Upgrade
Biological Reagent - Gene Sequencing Series Growth
-
Log In
Log In
Log In
Log In
Upgrade
Biological Reagent - Reverse Transcription Series
-
Log In
Log In
Log In
Log In
Upgrade
Biological Reagent - Reverse Transcription Series Growth
-
Log In
Log In
Log In
Log In
Upgrade
Point-of-care Testing Diagnostic Reagent - Quantum Dot Immunofluorescence Reagent
-
Log In
Log In
Log In
Log In
Upgrade
Point-of-care Testing Diagnostic Reagent - Quantum Dot Immunofluorescence Reagent Growth
-
Log In
Log In
Log In
Log In
Upgrade
Biological Reagent - Molecular Cloning Series
-
Log In
Log In
Log In
Log In
Upgrade
Biological Reagent - Molecular Cloning Series Growth
-
Log In
Log In
Log In
Log In
Upgrade
Point-of-care Testing Diagnostic Reagent - Fluorescence Polymerase Chain Reaction Nucleic Acid Detection Reagent
-
Log In
Log In
Log In
Log In
Upgrade
Biological Reagent - Extraction and Purification Series
-
Log In
Log In
Log In
Log In
Upgrade
Biological Reagent - Extraction and Purification Series Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
-
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
Biological Reagent - Cell/Protein Series
-
Log In
Log In
Log In
Log In
Upgrade
Biological Reagent - Cell/Protein Series Growth
-
Log In
Log In
Log In
Log In
Upgrade
Point-of-care Testing Diagnostic Equipment
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
China
1.00B
Log In
Log In
Log In
Log In
Upgrade
China Growth
-69.88%
Log In
Log In
Log In
Log In
Upgrade
Overseas
34.31M
Log In
Log In
Log In
Log In
Upgrade
Overseas Growth
-85.07%
Log In
Log In
Log In
Log In
Upgrade